Expression and significance of miRNA-21 and BTG2 in lung cancer

The efficacy of the inhalation of an aerosolized Group A streptococcal preparation in the treatment of lung cancer

(2013) Jun Liu et al.   Chinese Journal of Cancer Research

Roles for MicroRNAs in Conferring Robustness to Biological Processes

(2012) Margaret S. Ebert et al.   CELL

BTG2 suppresses cancer cell migration through inhibition of Src-FAK signaling by downregulation of reactive oxygen species generation in mitochondria

(2012) Seo-Kyung Lim et al.   CLINICAL & EXPERIMENTAL METASTASIS

DNA Damage Induces NF-κB-dependent MicroRNA-21 Up-regulation and Promotes Breast Cancer Cell Invasion

(2012) Jixiao Niu et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Clinical Outcome Prediction by MicroRNAs in Human Cancer: A Systematic Review

(2012) Viswam S. Nair et al.   JNCI-Journal of the National Cancer Institute

A novel source for miR-21 expression through the alternative polyadenylation of VMP1 gene transcripts

(2012) Judit Ribas et al.   NUCLEIC ACIDS RESEARCH

BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial–mesenchymal transition

(2012) V Coppola et al.   ONCOGENE

Effects of BTG2 on proliferation inhibition and anti-invasion in human lung cancer cells

(2012) Sen Wei et al.   TUMOR BIOLOGY

MicroRNA, Nutrition, and Cancer Prevention

(2012) Sharon A. Ross et al.   Advances in Nutrition

miR-21 may acts as an oncomir by targeting RECK, a matrix metalloproteinase regulator, in prostate cancer

(2012) Sabrina Thalita Reis et al.   BMC Urology

Aberrant Expression of the p53-Inducible Antiproliferative Gene BTG2 in Hepatocellular Carcinoma is Associated with Overexpression of the Cell Cycle-Related Proteins

(2011) Zhimin Zhang et al.   CELL BIOCHEMISTRY AND BIOPHYSICS

MicroRNA miR-21 Regulates the Metastatic Behavior of B16 Melanoma Cells

(2011) Chuan He Yang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Association of microRNA-21 expression with its targets, PDCD4 and TIMP3, in pancreatic ductal adenocarcinoma

(2011) Yuichi Nagao et al.   MODERN PATHOLOGY

Breast tumor progression induced by loss of BTG2 expression is inhibited by targeted therapy with the ErbB/HER inhibitor lapatinib

(2011) F Takahashi et al.   ONCOGENE

Downregulation of Spry2 by miR-21 triggers malignancy in human gliomas

(2011) H-J Kwak et al.   ONCOGENE

Clinicopathological and Prognostic Value of MicroRNA-21 and MicroRNA-155 in Colorectal Cancer

(2011) Hajime Shibuya et al.   ONCOLOGY

MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC)

(2010) Ji-guang Zhang et al.   CLINICA CHIMICA ACTA

MicroRNAs control hepatocyte proliferation during liver regeneration

(2010) Guisheng Song et al.   HEPATOLOGY

MicroRNA-21 Is a Downstream Effector of AKT That Mediates Its Antiapoptotic Effects via Suppression of Fas Ligand

(2010) Danish Sayed et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiforme

(2009) Yiming Li et al.   BRAIN RESEARCH

Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma

(2009) Min Liu et al.   CELL RESEARCH

The mammalian anti-proliferative BTG/Tob protein family

(2009) G. Sebastiaan Winkler   JOURNAL OF CELLULAR PHYSIOLOGY

Impact of BTG2 expression on proliferation and invasion of gastric cancer cells in vitro

(2009) Lin Zhang et al.   MOLECULAR BIOLOGY REPORTS

MicroRNA-21 Targets a Network of Key Tumor-Suppressive Pathways in Glioblastoma Cells

(2008) T. Papagiannakopoulos et al.   CANCER RESEARCH

miR-21 Gene Expression Triggered by AP-1 Is Sustained through a Double-Negative Feedback Mechanism

(2008) Shuji Fujita et al.   JOURNAL OF MOLECULAR BIOLOGY

p73α isoforms drive opposite transcriptional and post-transcriptional regulation of MYCN expression in neuroblastoma cells

(2008) Emilie Horvilleur et al.   NUCLEIC ACIDS RESEARCH